Stridex Xl Face and Body Pads

Description

STRIDEX® is an acne medication containing 2% w/w salicylic acid, formulated for maximum strength. The product is presented in the form of XL Face & Body Pads™, which are designed to provide effective treatment for acne. Each container includes 90 dual-textured pads, featuring one side for scrubbing and the other for gentle application. The pads are alcohol-free and incorporate pore-tightening grapefruit extract. Notably, these pads are 67% larger than standard options, enhancing their usability for both facial and body application.

Uses and Indications

This drug is indicated for the treatment of acne. It reduces the number of acne pimples and blackheads, facilitating skin healing. Additionally, it helps prevent the formation of new acne pimples.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The product should be applied using the provided pad, covering the entire affected area with a thin layer. Initial dosing should consist of one application daily, with the possibility of gradually increasing to two or three times daily based on clinical response or as directed by a physician.

It is important to monitor for excessive drying of the skin, which may necessitate a reduction in frequency of application. If bothersome dryness or peeling occurs, the application frequency should be adjusted to once daily or every other day.

The pad should not be left on the skin for an extended period, and care should be taken to avoid contact with the eyes, lips, and other mucous membranes.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients against using this product if they have a known allergy to salicylic acid, as this may lead to serious allergic reactions.

Patients should be cautioned that the likelihood of skin irritation and dryness increases when this product is used concurrently with other topical acne medications. In cases where irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised to ensure appropriate management.

Side Effects

For external use only. Patients should be advised not to use this product if they have a known allergy to salicylic acid, as this may lead to serious allergic reactions.

When using this product, skin irritation and dryness are common adverse reactions, particularly if another topical acne medication is used concurrently. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation. If irritation occurs, discontinuation of the product should be considered.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Stridex Xl Face and Body Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Stridex XL Face and Body Pads in geriatric patients. The prescribing information does not indicate any dosage adjustments, safety concerns, or special precautions that are specifically applicable to elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this product in patients aged 65 and older, as individual patient factors may influence treatment decisions. Monitoring for efficacy and potential adverse effects is recommended in this population, given the absence of targeted data.

Pregnancy

There is currently no information available regarding the use of Stridex XL Face and Body Pads during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering the use of this product in pregnant patients. Healthcare professionals are advised to exercise caution and consider the absence of data when discussing the use of this product with women of childbearing potential.

Lactation

Lactating mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk, and the effects on a nursing infant are not well studied; therefore, caution is advised.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with liver problems.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, it is important to inform patients about the potential for skin irritation and dryness. They should be cautioned that using this medication concurrently with another topical acne treatment may increase the likelihood of these side effects. If patients experience irritation, they should be advised to limit their use to one topical acne medication at a time to minimize adverse effects.

Storage and Handling

The product is supplied in a manner that emphasizes proper disposal and hygiene practices. Users are instructed to discard the pad in the trash and to wash their hands thoroughly after use.

It is important to note that the product should not be flushed down the toilet. This ensures compliance with waste management guidelines and promotes environmental safety.

Additional Clinical Information

The product is administered topically, with a recommendation to apply a thin layer using the pad to cover the entire affected area one to three times daily. Clinicians should advise patients to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if swallowed.

Patients should be counseled to use only one topical acne medication at a time to avoid irritation. If dryness or peeling becomes bothersome, they should reduce the application frequency to once daily or every other day. It is important to avoid leaving the pad on the skin for extended periods and to keep the product away from the eyes, lips, and other mucous membranes.

Drug Information (PDF)

This file contains official product information for Stridex Xl Face and Body Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)